Page 20 - தாக்கல் செய்யப்பட்டது வழங்கியவர் ஜும்ர் ஹோல்டிங்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தாக்கல் செய்யப்பட்டது வழங்கியவர் ஜும்ர் ஹோல்டிங்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தாக்கல் செய்யப்பட்டது வழங்கியவர் ஜும்ர் ஹோல்டிங்ஸ் Today - Breaking & Trending Today

Solvbl Solutions Inc. (Formerly Stowe One Investment Corp.) and Agile Blockchain Corp. Announce Closing of Business Combination and Filing of a Non-Offering Final Prospectus


Toronto, Ontario (Newsfile Corp. - February 18, 2021) - Solvbl Solutions Inc. (formerly Stowe One Investment Corp.) (
SoLVBL or the
Company ) and Agile Blockchain Corp. (
Agile ) are pleased to announce the completion of their previously-announced business combination which resulted in the reverse take-over of SoLVBL by Agile (the
Transaction ). As a result of the Transaction, SoLVBL now carries on the business of Agile. The Company is also pleased to announce that it has publicly filed, and been receipted for, a non-offering final prospectus dated February 10, 2021 (the
Prospectus ) in connection with the listing of its common shares (the
Common Shares ) on the Canadian Stock Exchange ( ....

South Africa , United States , United Kingdom , Vikas Gupta , Raymond Pomroy , Alan Rootenberg , Khurram Qureshi , Musabbir Chowdhury , Brenda Brown , Information Technology At Fleming College , Niagara College School Of Business , Stowe One Investment Corp So , Global Talent Management At Compass Group , Stowe One Investments Corp , Epi Lab , Solvbl Solutions Inc , Company Subco , Venture Exchange , Agile Blockchain Corp , Dh Media Inc , National Instrument , Academic Of Portage College In Alberta , Bc Ltd , Loughborough University United Kingdom , Canadian Stock Exchange , Stowe One Investment Corp ,

Xenetic Biosciences, Inc. Announces Partner's Filing of Registration Dossier in Russia for Epolong Product Candidate That Utilizes Xenetic's PolyXen(R) Platform Technology


(3)
PJSC Pharmsynthez is leveraging Xenetic s PolyXen® technology to improve the pharmacological properties of its Epolong product candidate pursuant to a royalty-bearing collaboration agreement
Russian registration filing of Epolong, a polysialylated form of recombinant human erythropoietin, follows previously reported positive Phase 3 data for the treatment of anemia in patients with chronic kidney disease
FRAMINGHAM, MA / ACCESSWIRE /
February 16, 2021 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ( Xenetic or the Company ), a biopharmaceutical company focused on advancing XCART, a personalized CAR T platform technology engineered to target patient- and tumor-specific neoantigens, today announced its partner, PJSC Pharmsynthez ( Pharmsynthez ), has reported in a press release that it has started the registration phase of Epolong (erythropoietin and polysialic acid conjugate) by filing a registration dossier to obtain approval of Epolong in Russia for the treatm ....

United States , Leningradskaya Oblast , Jenene Thomas , Xenetic Polyxen , Jeffrey Eisenberg , Xenetic Biosciences , Takeda Pharmaceuticals Co , Xenetic Biosciences Inc , Lipoxen Technologies , Lipoxen Technologies Limited , Chief Executive Officer , Takeda Pharmaceuticals , North American , Private Securities Litigation Reform Act , ஒன்றுபட்டது மாநிலங்களில் , ஜெஃப்ரி ஐசன்பெர்க் , டாகேடா மருந்துகள் இணை , தலைமை நிர்வாகி அதிகாரி , டாகேடா மருந்துகள் , வடக்கு அமெரிக்கன் , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் ,

TechnipFMC plc Announces Filing of Current Report on Form 8-K Disclosing Entry Into Certain Material Agreements Relating to TechnipFMC plc's Previously Announced Separation Into Two Industry-leading, Independent, Publicly Traded Companies


TechnipFMC plc Announces Filing of Current Report on Form 8-K Disclosing Entry Into Certain Material Agreements Relating to TechnipFMC plc s Previously Announced Separation Into Two Industry-leading, Independent, Publicly Traded Companies
TechnipFMC plc (
TechnipFMC ) (NYSE: FTI) (Paris: FTI) (ISIN: GB00BDSFG982) announces that on 16 February 2021, it filed a Current Report on Form 8-K (the
Form 8-K ) under the U.S. Securities Exchange Act of 1934, as amended, with the U.S. Securities and Exchange Commission (the
SEC ) disclosing TechnipFMC s entry into certain material agreements relating to TechnipFMC s previously announced separation into two industry-leading, independent, publicly traded companies.
On February 15 and 16, 2021, TechnipFMC plc (the Company ) entered into certain agreements related to its separation into two industry-leading, independent, publicly traded companies: the Company, a fully integrated technology and services provider; and Te ....

New York , United States , France General , United Kingdom , City Of , Marie Ange Debon , Matt Seinsheimer , Didier Houssin , Arnaud Pieton , Technip Energie , Pascal Colombani , Arnaud Caudoux , Olivier Piou , Joseph Rinaldi , Christophe Belorgeot , Phillip Lindsay , Brooke Robertson , Sumitomo Mitsui Banking Corporation , Exchange Commission On , Us Bank National Association , European Union , Bofa Securities Inc , Parent Company , Technologies Employee Retirement Program , Company To Technip Energies , Company Technip Energies ,